Mealey's (May 16, 2023, 5:35 PM EDT) -- NEW YORK — The New York federal judge overseeing the acetaminophen autism spectrum disorder (ASD) attention-deficit/hyperactivity disorder (ADHD) multidistrict litigation has invited the Food and Drug Administration to submit its views on whether a new pregnancy warning should be required on all acetaminophen products and whether current science warrants a new warning label or advice about in utero exposure to the anti-inflammatory product....